InvestorsHub - NYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News

Ticker	Name	Price	Change	Change %	Volume	Posts
AREB	American Rebel Holdings Inc	19.50	15.54	392.42%	83,206,175	365
AEHL	Antelope Enterprise Holdings Ltd	4.20	2.10	100.00%	11,164,888	54
CXAI	CXApp Inc	1.41	0.6040	74.86%	92,259,155	453
XHG	XChange TED Inc	1.11	0.3700	50.00%	2,994,677	121
WCT	Wellchange Holdings Company Limited	0.2790	0.0840	43.08%	208,108,690	22
SOBR	SOBR Safe Inc	4.93	1.46	42.03%	1,275,545	1,050
MHLD	Maiden Holdings Ltd	0.7948	0.2301	40.75%	630,544	43
FORD	Forward Industries Inc	6.87	1.95	39.63%	546,577	293
RGC	Regencell Bioscience Holdings Ltd	33.20	8.90	36.60%	265,350	407
ICCT	iCoreConnect Inc	5.69	1.46	34.51%	83,114,588	3,663

Ticker	Board Name	Price	Change %	Posts (24h)
FNMA	Fannie Mae-No Politics	5.65	-7.68%	134
LWLG	Lightwave Logic Inc	0.9001	0.00%	95
COOP	Mr Cooper Group Inc	133.70	+0.45%	60
ASII	Accredited Solutions Inc	0.0003	-16.25%	47
NB	Niocorp Developments Ltd	1.91	-8.61%	29
TPTW	TPT Global Tech Inc	0.0001	0.00%	28

	Board Name	Posts (24h)
	ORIONS Money Stocks	70
	DD Support Board and Research Team	79
	BBs Stock Haven	101
4	Savvy Trades and Investments	33
5	MOMOS BREAKOUT BOARD	62
6	Mohacsys Safe Portfolio Member Forum	46

Ticker	Name	Price	Change %	Market Cap	Volume ($)
BTC	Bitcoin	82,720.00	-1.33%	1,648.2B	4.0B	Message Board Quote News
MBOX	Mobox	3,985.00	-100.00%	1,635.5B	2.5M	Quote News
PHB	Phoenix Global	31,159.48	-100.00%	1,607.9B	817,985	Message Board Quote News
BETA	Beta Token	1,372.38	-100.00%	1,225.3B	793,773	Quote News
UTK	UTRUST	2,299.77	-100.00%	1,093.1B	33.9B	Message Board Quote News
NULS	Nuls	6,887.31	-100.00%	771.2B	430,115	Message Board Quote News
CFX	Conflux	136.02	2.04%	669.5B	12.8M	Quote News
FTT	FTX Token	1,656.82	-1.66%	221.4B	3.0B	Message Board Quote News
ETH	Ethereum	1,810.97	-0.26%	218.3B	1.5B	Message Board Quote News
USDT	Tether USD	0.9997	0.00%	141.9B	247.6M	Message Board Quote News

Play Episode

7min

Proactive - Interviews for investors

Titan Mining reports record 2024 production, expands resources

Titan Mining President Rita Adiani joined Steve Darling from Proactive to discuss the company’s year-end results, highlighting record production and strong financial performance in 2024. The company met the upper end of its production guidance, while costs were 10% lower than the low end of its all-in sustaining cost (AISC) guidance. In Q4 2024, Titan Mining produced 21.7 million pounds of payable zinc, marking a 56% increase compared to Q4 2023. Total full-year 2024 production reached 59.5 million pounds. The company also posted Q4 revenues of $26.3 million, representing a 318% increase from Q3 2024 and a 241% increase from Q4 2023. Adiani also shared updates on the company’s mineral resource expansion, noting that Titan completed an updated mineral resource estimate and extended the mine life for ESM’s zinc operations until 2033. The updated estimate reports a 22% increase in measured and indicated contained zinc pounds compared to the 2020 resource estimate. In addition to its zinc operations, Titan completed a maiden mineral resource estimate for the Kilbourne Graphite Project. The project now holds an open-pit constrained inferred mineral resource of 22 million U.S. short tons, with an average grade of 2.91% (Cg), containing 653,000 tons of graphite at a 1.50% cut-off grade. #proactiveinvestors #titanminingcorporation #tsx #ti #otcqb #timcf #TitanMining #ZincProduction #GraphiteMining #BatteryMetals #CriticalMinerals #MiningStocks #TSX #RitaAdiani #EVMaterials #GraphiteUSA #MiningExpansion #AgustaGroup #ProactiveInvestors

Proactive - Interviews for investors

Krakatoa’s antimony-gold find signals major upside

Krakatoa Resources Ltd chairman Colin Locke talked with Proactive about the company’s newly secured Zopkhito Project in Georgia, which he described as a major opportunity for investors. The project contains a JORC resource of 225,000 tonnes of high-grade antimony at 11% for 26,000 tonnes of metal, translating to a back-of-the-envelope valuation of approximately $1.30 billion based on current prices. Additionally, the project includes 7.1 million tonnes grading 3.7g/t gold for 815,000 ounces, estimated to be worth around $2.50 billion. Locke said, “This is touted to be the sixth biggest antimony project in the world.” The mineralisation is close to surface, and the company believes the resource has strong potential for expansion. He also highlighted the project’s additional gold content as another value driver. He attributed the company’s success in securing the project to its CEO and chief technical officer, Mark Major, whose experience in high-altitude exploration was a key factor for the local vendors. The project’s location in Georgia was described as highly investor-friendly, with a 15% corporate tax rate, no native title or land access complications, and strong support for foreign investment. Locke confirmed that a maiden drilling program is scheduled to begin shortly, with Major heading to Georgia next week to prepare. He emphasised the company’s past success with international projects and reassured investors of the team’s experience. In closing, he noted the company's current market capitalisation of just AUD 5 million, suggesting significant upside. 👉 For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to the channel, and turn on notifications for future updates. #ProactiveInvestors #KrakatoaResources #ASX #gold #antimony

Proactive - Interviews for investors

OKYO Pharma achieves key stability milestone for Urcosimod in clinical development

OKYO Pharma CEO Gary Jacob joined Steve Darling from Proactive to share a significant advancement in the company’s ongoing drug development efforts. The company has successfully demonstrated that urcosimod—formerly known as OK-101—remains stable for more than two and a half years in single-use ampoules, which are used for patient administration. This milestone is a crucial step forward in ensuring the long-term viability of the drug as it progresses through clinical trials. Urcosimod is currently being evaluated in a Phase 2b clinical trial, which is a randomized, placebo-controlled, double-masked study involving 48 patients. The trial is focused on assessing the drug’s effectiveness in treating neurotrophic keratopathy (NCP), a serious and progressive degenerative eye disease. Jacob emphasized that achieving success in clinical development extends beyond obtaining positive clinical trial data. A crucial aspect of regulatory approval includes meeting the rigorous Chemistry, Manufacturing, and Controls (CMC) requirements set by the U.S. Food and Drug Administration (FDA). By demonstrating long-term stability, OKYO Pharma has strengthened its regulatory submission package, addressing an essential factor in the drug’s future approval and commercialization. The company recently completed Good Manufacturing Practice (GMP) stability assay testing of single-use ampoules containing urcosimod in an ophthalmic solution. The results were highly promising—ampoules stored under refrigerated conditions maintained stability for over two and a half years, while initial three-month data from samples stored at room temperature showed potency levels at or above 100%. These findings reinforce confidence in urcosimod’s shelf life and its potential for real-world clinical use. As OKYO Pharma continues to advance urcosimod through the regulatory and clinical development process, this stability milestone represents a critical achievement in its journey toward providing an effective tr

Proactive - Interviews for investors

Tamboran Resources boosts NT gas supply with Arafura deal

Tamboran Resources Ltd CEO Joel Riddle talked with Proactive about the company's newly signed letter of intent (LOI) with Arafura Resources Ltd to supply gas from the Beetaloo Basin. Riddle explained that both companies are based in the Northern Territory, and the agreement supports local strategic projects by providing 25 terajoules (TJs) per day to Arafura's critical minerals project. The agreement aligns with Tamboran’s strategy of prioritising Northern Territory gas use. “We’re a Northern Territory company. We’ve been focused on appraising the Beetaloo Basin now for all 12 years I’ve been in my job,” Riddle said, highlighting the company’s long-term commitment to the region. Riddle also pointed out the environmental edge of Beetaloo Basin gas, which has a CO2 content of about 3%, significantly lower than the 15–20% typically found in other Australian basins. He said supplying this low-carbon gas to the East Coast would help reduce emissions by displacing higher-carbon alternatives. Discussing supply capacity, Riddle compared the Beetaloo to the Marcellus Shale in the US, noting it could provide enough gas to support the East Coast for “hundreds of years”. Tamboran plans to bring 40 TJs per day online in the first half of next year under an existing 15-year agreement with the NT Government. The Arafura deal will add a further 25 TJs daily. Riddle said work is underway with pipeline partner APA to ensure infrastructure capacity. The company aims to finalise a binding gas sales agreement with Arafura soon. Watch the full interview to hear how Tamboran is positioning Beetaloo gas as a key part of the East Coast supply solution, while supporting Northern Territory industry. 👉 For more interviews and updates, visit Proactive's YouTube channel. Don’t forget to like the video, subscribe, and hit the notification bell for future content. #TamboranResources #BeetalooBasin #LowCarbonGas #GasSupply #ArafuraResources #EastCoastEnergy #NorthernTerritory #CriticalMiner

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Trade War Concerns Lead To Extended Nosedive On Wall Street

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Trade War Concerns Lead To Extended Nosedive On Wall Street

Go Ad-Free